{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:28:06Z","timestamp":1790803686233,"version":"4.1.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,22]]},"DOI":"10.7759\/cureus.23411","type":"journal-article","created":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T06:04:36Z","timestamp":1648015476000},"source":"Crossref","is-referenced-by-count":3,"title":["Tocilizumab and Baricitinib for Recovery From Acute Exacerbation of Combined Pulmonary Fibrosis and Emphysema Secondary to COVID-19 Infection: A Case Report"],"prefix":"10.7759","author":[{"given":"Yoshiro","family":"Kai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehito","family":"Kasamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Kajita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Uno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Muro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.731847","article-title":"Immunotherapy summary for cytokine storm in COVID-19","volume":"12","author":"Li Y","year":"2021","unstructured":"Li Y, Zhao W, Liu J, Chen Z, Lv Q, Zhang Z. Immunotherapy summary for cytokine storm in COVID-19. Front Pharmacol. 2021, 12:731847. 10.3389\/fphar.2021.731847","journal-title":"Front Pharmacol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00540-021-02974-0","article-title":"Tocilizumab in patients with COVID-19: which patient, time, and dose?","volume":"35","author":"Hasanin A","year":"2021","unstructured":"Hasanin A, Mostafa M. Tocilizumab in patients with COVID-19: which patient, time, and dose?. J Anesth. 2021, 35:896-902. 10.1007\/s00540-021-02974-0","journal-title":"J Anesth"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00358-1","article-title":"Baricitinib: the first immunomodulatory treatment to reduce COVID-19 mortality in a placebo-controlled trial","volume":"9","author":"Kalil AC","year":"2021","unstructured":"Kalil AC, Stebbing J. Baricitinib: the first immunomodulatory treatment to reduce COVID-19 mortality in a placebo-controlled trial. Lancet Respir Med. 2021, 9:1349-51. 10.1016\/S2213-2600(21)00358-1","journal-title":"Lancet Respir Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0233147","article-title":"Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis","volume":"15","author":"Alqahtani JS","year":"2020","unstructured":"Alqahtani JS, Oyelade T, Aldhahir AM, et al.. Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis. PLoS One. 2020, 15:e0233147. 10.1371\/journal.pone.0233147","journal-title":"PLoS One"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202006-2441LE","article-title":"Increased odds of death for patients with interstitial lung disease and COVID-19: a case-control study","volume":"202","author":"Esposito AJ","year":"2020","unstructured":"Esposito AJ, Menon AA, Ghosh AJ, et al.. Increased odds of death for patients with interstitial lung disease and COVID-19: a case-control study. Am J Respir Crit Care Med. 2020, 202:1710-3. 10.1164\/rccm.202006-2441LE","journal-title":"Am J Respir Crit Care Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26038","article-title":"Clinical outcomes in COVID-19 patients treated with tocilizumab: an individual patient data systematic review","volume":"92","author":"Antwi-Amoabeng D","year":"2020","unstructured":"Antwi-Amoabeng D, Kanji Z, Ford B, Beutler BD, Riddle MS, Siddiqui F. Clinical outcomes in COVID-19 patients treated with tocilizumab: an individual patient data systematic review. J Med Virol. 2020, 92:2516-22. 10.1002\/jmv.26038","journal-title":"J Med Virol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1172\/JCI141772","article-title":"Baricitinib restrains the immune dysregulation in patients with severe COVID-19","volume":"130","author":"Bronte V","year":"2020","unstructured":"Bronte V, Ugel S, Tinazzi E, et al.. Baricitinib restrains the immune dysregulation in patients with severe COVID-19. J Clin Invest. 2020, 130:6409-16. 10.1172\/JCI141772","journal-title":"J Clin Invest"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.reuma.2020.10.009","article-title":"Experience with the use of baricitinib and tocilizumab monotherapy or combined, in patients with interstitial pneumonia secondary to coronavirus COVID19: a real-world study","volume":"18","author":"Rosas J","year":"2020","unstructured":"Rosas J, Lia\u00f1o FP, Cant\u00f3 ML, et al.. Experience with the use of baricitinib and tocilizumab monotherapy or combined, in patients with interstitial pneumonia secondary to coronavirus COVID19: a real-world study. Reumatol Clin (Engl Ed). 2020, 18:150-6. 10.1016\/j.reuma.2020.10.009","journal-title":"Reumatol Clin (Engl Ed)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/91003-tocilizumab-and-baricitinib-for-recovery-from-acute-exacerbation-of-combined-pulmonary-fibrosis-and-emphysema-secondary-to-covid-19-infection-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:42:30Z","timestamp":1707507750000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/91003-tocilizumab-and-baricitinib-for-recovery-from-acute-exacerbation-of-combined-pulmonary-fibrosis-and-emphysema-secondary-to-covid-19-infection-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,22]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.23411","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,22]]}}}